Trial NCT03277352

View at ClinicalTrials.gov 
Org. Study IDs: INCAGN 1876-202

Last trial update was posted on 2021-07-22

MeSH Interventions

Pembrolizumab

MeSH Conditions

Neoplasms

Other Conditions

Advanced Malignancies Metastatic Cancer

Stopping Reasons

The study was terminated due to emergent data from another study and unrelated to safety.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID